Effectiveness of Highly Active Antiretroviral Therapy in Reducing Heterosexual Transmission of HIV

Highly active antiretroviral therapy (HAART) has been shown to be highly effective in reducing plasma levels of HIV RNA; therefore, these treatments could diminish the risk of transmission. We analyzed 393 steady heterosexual couples, of which one partner had been previously diagnosed with HIV infection (index case) and where the nonindex partner reported his or her sexual relationship with the index case as the unique risk exposure. These couples were consecutively enrolled in the period 1991 through 2003 when the nonindex partners took their first HIV test. HIV prevalence among partners of index cases who had not received antiretroviral therapy was 8.6%, whereas no partner was infected in couples in which the index case had been treated with HAART (P = 0.0123). HIV prevalence among nonindex partners declined from 10.3% during the pre-HAART period (1991-1995) to 1.9% during the late HAART period (1999-2003; P = 0.0061). In the multivariate analysis, this decline held (odds ratio = 0.14, 95% confidence interval: 0.03-0.66) after adjusting for length of partnership, unprotected coitus, and pregnancies as well as gender, CD4+ lymphocyte count, AIDS-defining diseases, and sexually transmitted infections in the index case. When HAART became widely available, a reduction of approximately 80% in heterosexual transmission of HIV was observed, irrespective of changes in other factors that affect transmission.

[1]  S. Hammer,et al.  Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. , 1997, JAMA.

[2]  B. Rewari,et al.  Antiretroviral Therapy for HIV Infection , 2007 .

[3]  L. Meyer,et al.  Sexual behavior changes and protease inhibitor therapy. SEROCO Study Group. , 2000, AIDS.

[4]  S. Hammer,et al.  Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. , 1996, JAMA.

[5]  Maureen Miller,et al.  Sexual behavior changes and protease inhibitor therapy , 2000 .

[6]  J. Chmiel,et al.  Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men , 2002, AIDS.

[7]  A. van der Straten,et al.  Sexual risk behaviors among heterosexual HIV serodiscordant couples in the era of post-exposure prevention and viral suppressive therapy , 2000, AIDS.

[8]  S. Hammer,et al.  Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. , 1998, JAMA.

[9]  P. Waight,et al.  Incidence of HIV infection among homosexual men. , 1991, BMJ.

[10]  Jeffrey N. Martin,et al.  Decline in HIV infectivity following the introduction of highly active antiretroviral therapy , 2003, AIDS.

[11]  HOMAS,et al.  VIRAL LOAD AND HETEROSEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VIRAL LOAD AND HETEROSEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 , 2000 .

[12]  J. Alcamí,et al.  Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner. , 1999, Journal of acquired immune deficiency syndromes.

[13]  J. Callen.  A longitudinal study of human immunodeficiency virus transmission by heterosexual partners: de Vincenzi I for the European Study Group on Heterosexual Transmission of HIV. N Engl J Med 1994;331:341–346 , 1995 .

[14]  Ronald H Gray,et al.  Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda , 2003, AIDS.

[15]  A. Telenti,et al.  Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study. , 2003, Journal of acquired immune deficiency syndromes.

[16]  M A Fischl,et al.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. , 1997, The New England journal of medicine.

[17]  A. Lazzarin,et al.  Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men. , 1993, Journal of acquired immune deficiency syndromes.

[18]  R. Gelber,et al.  "Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type I with Zidovudine Treatment." , 1994 .

[19]  P. Vernazza,et al.  Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  L. Meyer,et al.  Increase in at-risk sexual behaviour among HIV-1-infected patients followed in the French PRIMO cohort , 2002, AIDS.

[21]  A. Lazzarin,et al.  Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission. , 1994 .

[22]  D. Stram,et al.  Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group. , 1997, American journal of epidemiology.

[23]  Roger Detels,et al.  Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.

[24]  A. Lazzarin,et al.  Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission. , 1994, Archives of internal medicine.

[25]  D. Pillay,et al.  The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis , 2002, AIDS.

[26]  L. Kingsley,et al.  High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors , 1997, Journal of virology.

[27]  D. Vlahov,et al.  Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users , 2002, Journal of epidemiology and community health.

[28]  T. Wright,et al.  Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. , 1999, The Journal of infectious diseases.

[29]  I. de Vincenzi,et al.  A Longitudinal Study of Human Immunodeficiency Virus Transmission by Heterosexual Partners , 1994 .

[30]  R. Royce,et al.  Sexual transmission of HIV. , 1997, The New England journal of medicine.

[31]  Steven Gibson,et al.  Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. , 2002, American journal of public health.

[32]  Mirjam Kretzschmar,et al.  The contribution of steady and casual partnerships to the incidence of HIV infection among homosexual men in Amsterdam , 2003, AIDS.